There is also a need to study inflammatory markers in CSF and—as central inflammation can be assessed using positron emission tomography (PET) ligands specific for the translocator protein (TPSO)—to undertake in vivo PET studies both during depression and after recovery. Here, TSPO is linked to major depressive disorder.